Results From a Randomized Phase III Study Comparing Combined Treatment With Histamine Dihydrochloride Plus Interleukin-2 Versus Interleukin-2 Alone in Patients With Metastatic Melanoma

Journal article

Peer reviewed

S. S Agarwala

Journal of clinical oncology, Vol.20(1), pp.125-133

2002-01-01

PMID: 11773161

Metrics

3 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.159 Membrane Channels & Receptors; 1.159.1806 Histamine
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Results From a Randomized Phase III Study Comparing Combined Treatment With Histamine Dihydrochloride Plus Interleukin-2 Versus Interleukin-2 Alone in Patients With Metastatic Melanoma
Creators: S. S Agarwala
Publication Details: Journal of clinical oncology, Vol.20(1), pp.125-133
Language: English
Resource Type: Journal article
PMID: 11773161
Record Identifier: 991031614612902976